272 related articles for article (PubMed ID: 29466694)
1. Lipid pathway deregulation in advanced prostate cancer.
Galbraith L; Leung HY; Ahmad I
Pharmacol Res; 2018 May; 131():177-184. PubMed ID: 29466694
[TBL] [Abstract][Full Text] [Related]
2. SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.
Audet-Walsh É; Vernier M; Yee T; Laflamme C; Li S; Chen Y; Giguère V
Mol Cancer Res; 2018 Sep; 16(9):1396-1405. PubMed ID: 29784665
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the development of protein-protein interaction inhibitors targeting androgen receptor-coactivator binding in prostate cancer.
Biron E; Bédard F
J Steroid Biochem Mol Biol; 2016 Jul; 161():36-44. PubMed ID: 26196120
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
[TBL] [Abstract][Full Text] [Related]
8. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
Wen S; Niu Y; Lee SO; Yeh S; Shang Z; Gao H; Li Y; Chou F; Chang C
Mol Carcinog; 2016 Dec; 55(12):2278-2290. PubMed ID: 26894509
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipogenesis and induction of apoptosis by valproic acid in prostate cancer cells via the C/EBPα/SREBP-1 pathway.
Pang B; Zhang J; Zhang X; Yuan J; Shi Y; Qiao L
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):354-364. PubMed ID: 33471067
[TBL] [Abstract][Full Text] [Related]
10. Pistachio Consumption Prevents and Improves Lipid Dysmetabolism by Reducing the Lipid Metabolizing Gene Expression in Diet-Induced Obese Mice.
Terzo S; Caldara GF; Ferrantelli V; Puleio R; Cassata G; Mulè F; Amato A
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513740
[TBL] [Abstract][Full Text] [Related]
11. Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
Ahmad I; Mui E; Galbraith L; Patel R; Tan EH; Salji M; Rust AG; Repiscak P; Hedley A; Markert E; Loveridge C; van der Weyden L; Edwards J; Sansom OJ; Adams DJ; Leung HY
Proc Natl Acad Sci U S A; 2016 Jul; 113(29):8290-5. PubMed ID: 27357679
[TBL] [Abstract][Full Text] [Related]
12. The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk.
Altuna-Coy A; Ruiz-Plazas X; Sánchez-Martin S; Ascaso-Til H; Prados-Saavedra M; Alves-Santiago M; Bernal-Escoté X; Segarra-Tomás J; R Chacón M
BMC Med; 2022 Aug; 20(1):255. PubMed ID: 35978404
[TBL] [Abstract][Full Text] [Related]
13. Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis.
Gu Y; Xue M; Wang Q; Hong X; Wang X; Zhou F; Sun J; Wang G; Peng Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948018
[No Abstract] [Full Text] [Related]
14. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.
Huang WC; Zhau HE; Chung LW
J Biol Chem; 2010 Mar; 285(11):7947-56. PubMed ID: 20071336
[TBL] [Abstract][Full Text] [Related]
16. A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth.
Gillis JL; Hinneh JA; Ryan NK; Irani S; Moldovan M; Quek LE; Shrestha RK; Hanson AR; Xie J; Hoy AJ; Holst J; Centenera MM; Mills IG; Lynn DJ; Selth LA; Butler LM
Elife; 2021 Aug; 10():. PubMed ID: 34382934
[TBL] [Abstract][Full Text] [Related]
17. Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells
Singh KB; Hahm ER; Pore SK; Singh SV
Mol Cancer Ther; 2019 Oct; 18(10):1800-1810. PubMed ID: 31395683
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network.
Sun Y; Guo W; Guo Y; Lin Z; Wang D; Guo Q; Zhou Y
Food Chem Toxicol; 2022 Nov; 169():113450. PubMed ID: 36208653
[TBL] [Abstract][Full Text] [Related]
19. Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR.
Hsieh PF; Jiang WP; Basavaraj P; Huang SY; Ruangsai P; Wu JB; Huang GJ; Huang WC
Phytomedicine; 2021 Dec; 93():153806. PubMed ID: 34740154
[TBL] [Abstract][Full Text] [Related]
20. Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno-geographic variations.
Lethongsavarn V; Pinault M; Diedhiou A; Guimaraes C; Guibon R; Bruyère F; Mathieu R; Rioux-Leclercq N; Multigner L; Brureau L; Fournier G; Doucet L; Blanchet P; Fromont G
Prostate; 2021 Dec; 81(16):1365-1373. PubMed ID: 34516695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
